疏血通治疗肺纤维化的临床疗效分析

目的：探讨采用疏血通对肺纤维化患者完成治疗后获得的临床效果。方法方便选择该院2010—2015年肺纤维化患者70例作为此次实验的研究对象。根据对肺纤维化患者采取的不同治疗方法展开分组。临床选择强的松药物对35例对照组肺纤维化患者进行治疗；临床选择疏血通药物对35例观察组肺纤维化患者进行治疗；最终对患者的肺功能、动脉血气结果以及肺部CT结果等实施对比。结果在治疗显效率方面，观察组(51.43%)明显高于对照组(17.14%)肺纤维化患者，且差异有统计学意义（P<0.05）。结论对肺纤维化患者，临床选择疏血通药物进行治疗，可以将肺纤维化患者的临床疗效以及肺功能显著改善，最终显著提高肺纤维化患者的生活质量。

Clinical Efficacy Shuxuetong Treatment of Pulmonary Fibrosis

Objective To evaluate the clinical effect after shuxuetong pulmonary fibrosis patients complete treatment avail-able. Methods Convenient selection hospital Year 2010 - 2015, 70 patients with pulmonary fibrosis as the experimental subjects. Depending on the method of treatment for patients with pulmonary fibrosis taken to expand packet. Clinical selec-tion of prednisone drugs in 35 cases in the control group patients with pulmonary fibrosis treatment; clinical choose shuxue-tong drugs in 35 cases of lung fibrosis was observed in patients treated; ultimately the patient's lung function, lung CT and arterial blood gas results like the implementation of the comparison. Results In the treatment efficiency,(51.43%) of the ob-servation group was obviously higher than that of control group (17.14%) patients with pulmonary fibrosis, the difference is statistically significant (P< 0.05). Conclusion Pulmonary fibrosis patients, clinical choose Shuxuetong drug treatment, can significantly improve the clinical efficacy in patients with pulmonary fibrosis and lung function, and ultimately significantly improve the quality of life of patients with pulmonary fibrosis.